TrialNeuro-oncology2016

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.

Bogdana Suchorska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.